Neogen Corporation reported fiscal fourth quarter and full year 2026 results on July 30, 2026. Q4 revenue was $225.3 million (Core Growth 4.3%), with Food Safety up 3.1% and Animal Safety down 8.2%. The company posted a net loss of $11.3 million ($0.05 per share) but Adjusted Net Income of $18.7 million ($0.09 per share). Full year revenue was $870.4 million with a net loss of $7.9 million. Neogen provided FY2027 guidance for revenue of $880-$885 million and Adjusted EBITDA of $180-$182 million. The company is progressing toward the sale of its Genomics business to Zoetis Inc., with regulatory reviews ongoing in Australia and New Zealand, targeting closure by H1 FY27 for approximately $140 million net proceeds. Manufacturing transitions for Petrifilm are scheduled to begin in November 2026. Neogen Corporation operates in the food safety and animal safety solutions industry.